Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 6, 2010, Pages 800-805

  Ferreira Silva, Márcia M ^a   Pereira, Gilberto A ^a   Lages Silva, Eliane ^a   Moraes Souza, Helio ^a,b  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FUNDAÇÃO HEMOMINAS   (Brazil)

Author keywords

Blood donors; Chagas disease; Inconclusive serology; Serological ineligibility; Socioepidemiological screening

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 77958012971     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762010000600012     Document Type: Article

References (25)

1. AABB - American Association of Blood Banks 2007. [homepage on the internet]. Chagas' disease: Results of T. cruzi antibody donor testing; c1998-03 [updated 2007 march 13; cited 2009 july 21]. Available from: aabb.org/Content/Programs_and_Services/Government_Regulatory_Issues/usmaptcruzi.htm.
2. ANVISA - Agência Nacional de Vigilância Sanitária 2002. [homepage on the internet]. Relatório de Produção da Hemorede em 2002: perfil sorológico dos doadores [updated 2002 December 13; cited 2004 march 10]. Available from: anvisa.gov.br.
3. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL 2008. Chagas disease and the US blood supply. Curr Opin Infect Dis 21:476-482.
4. Briceño-León R 2009. La enfermedad de Chagas en las Américas: una perspectiva de ecosalud. Cad Saude Publica 25 (Suppl. 1): S71-82.
5. Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES 2007. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 14:1045-1049.
6. Castro E 2009. Chagas' disease: lessons from routine donation testing. Transfus Med 19: 16-23.
7. Comeau P 2007. Canadian blood services to screen for Chagas disease. CMAJ 177:242.
8. Dias JC 1993. Chagas' disease and its control in Latin America: an analysis of possibilities. Cad Saude Publica 9: 201-209.
9. Dias JCP 2007. Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives. Mem Inst Oswaldo Cruz 102 (Suppl. I): 11-18.
10. Dias JCP 2009. Elimination of Chagas disease transmission: perspectives. Mem Inst Oswaldo Cruz 104 (Suppl. I): 41-45.
11. Dias JCP, Silveira AC, Schofield CJ 2002. The impact of Chagas disease control in Latin America - A review. Mem Inst Oswaldo Cruz 97: 603-612.
12. Ferreira-Silva MM 2006. Sensibilidade e especificidade dos testes sorológicos para doença de Chagas usados na triagem sorológica de doadores de sangue, Master's Thesis, Universidade Federal do Triângulo Mineiro, Uberaba, 86 pp.
13. Furuchó CR, Umezawa ES, Almeida I, Freitas VL, Bezerra R, Nunes EV, Sanches MC, Guastini CM, Teixeira AR, Shikanai-Yasuda MA 2008. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response. Trop Med Int Health 13: 1527-1533.
14. Garraud O, Andreu G, Elghouzzi MH, Laperche S, Lafrère JJ 2007. Measures to prevent transfusion-associated protozoal infections in non-endemic countries. Travel Med Infect Dis 5: 110-112.
15. Guariento ME, Almeida EA, Gilli SC 1996. Perfil do doador de sangue infectado pelo T. cruzi em Campinas, SP: avaliando a partir de seu grau de risco para a enfermidade. Rev Soc Bras Med Trop 2: 27-29.
16. Melo AS, Lorena VMB, Moraes AB, Pinto MBA, Leão SC, Soares AKA, Gadelha MFS, Gomes YM 2009. The prevalence of chagasic infection among blood donors in the state of Pernambuco, Brazil. Rev Bras Hematol Hemoter 31: 69-73.
17. Moraes-Souza H, Martins PRJ, Ferreira-Silva MM, Pereira GA, Abud MB 2006. Serological profile concerning Chagas disease of blood donors at Uberaba Blood Center. Rev Bras Hematol Hemoter 28: 110-114.
18. O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon MA 2009. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 48: 755-761.
19. OPS - Organización Panamericana de la Salud 2006. Estimación cuantitativa de la enfermedad de Chagas en las Americas, OPS, Geneva, 28 pp.
20. Piron M, Vergés M, Muños J, Casamitjana N, Sanz S, Maymó RM, Hernández JM, Puig L, Portús M, Gascón J, Sauleda S 2008. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 48: 1862-1868.
21. Prata A 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92-100.
22. Reesink HW 2005. European strategies against the parasite transfusion risk. Transfus Clin Biol 12:1-4.
23. Salles NA, Sabino EC, Cliquet MG, Eluf-Neto J, Mayer A, Almeida-Neto C, Mendonça MC, Dorliach-Llacer P, Chamone DF, Saéz-Alquézar A 1996. Risk of exposure to Chagas disease among seroreactive Brazilian blood donors. Transfusion 36: 969-973.
24. Schmunis GA 2007. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102 (Suppl. I): 75-85.
25. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Ponce E, Henriquez D, Revollo S, Espinoza B, Sousa O, Khan B, da Silveira JF 2004. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol 42:449-452.